Home / Brands / Lloyd Inc. of Iowa
Lloyd Inc. of Iowa Recalls
36 recalls on record · December 12, 2012 to May 29, 2013 · Drugs
Recalls by year
12
13
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP), 200 mcg, RX only, 100 tablets per bottle. Manufactured for Forest Pharma
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP), 175 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharma
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP), 150 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharma
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP), 137 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharma
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP) , 125 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharm
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP), 112 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharma
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP), 100 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharma
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Lloyd Thyro-Tab 0.200 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The f
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Lloyd Thyro-Tab 0.175 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The f
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Lloyd Thyro-Tab 0.150 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The f
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Lloyd Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The f
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Lloyd Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The f
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Lloyd Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The f
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Lloyd Thyro-Tab 0.100 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The f
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Lloyd Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The f
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP), 88 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmac
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Lloyd Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The f
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP) , 75 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharma
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Lloyd Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The f
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
May 29, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharma
Hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
January 2, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured fo
Hazard: Subpotent; 9-month stability interval
January 2, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Phar
Hazard: Subpotent; 9-month stability interval
January 2, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured fo
Hazard: Subpotent; 9-month stability interval
January 2, 2013DrugsFDA
Lloyd Inc. of Iowa recalls Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Phar
Hazard: Subpotent; 9-month stability interval
December 12, 2012DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP), 300 mcg., 100-count bottles, Rx only, NDC 0456-1328-01, Manufactured f
Hazard: cGMP Deviations; does not meet in process specification requirements
December 12, 2012DrugsFDA
Lloyd Inc. of Iowa recalls Thyro-Tab 0.300 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Phar
Hazard: cGMP Deviations; does not meet in process specification requirements
December 12, 2012DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP), 137 mcg., 100-count bottles, Rx only, NDC 0456-1331-01, Manufactured f
Hazard: cGMP Deviations; does not meet in process specification requirements
December 12, 2012DrugsFDA
Lloyd Inc. of Iowa recalls Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Phar
Hazard: cGMP Deviations; does not meet in process specification requirements
December 12, 2012DrugsFDA
Lloyd Inc. of Iowa recalls Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01, Manufactured fo
Hazard: cGMP Deviations; does not meet in process specification requirements
December 12, 2012DrugsFDA
Lloyd Inc. of Iowa recalls Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Phar
Hazard: cGMP Deviations; does not meet in process specification requirements